ロード中...
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
INTRODUCTION: Studies measuring the effectiveness of risk minimization measures (RMMs) submitted by pharmaceutical companies to the European Medicines Agency are part of the post-authorization regulatory requirements and represent an important source of data covering a range of medicinal products an...
保存先:
| 出版年: | Drug Saf |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808048/ https://ncbi.nlm.nih.gov/pubmed/29124666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-017-0604-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|